Mexico · Delayed Price · Currency is MXN Genomma Lab Internacional Statistics
Total Valuation
BMV:LAB.B has a market cap or net worth of MXN 14.82 billion. The enterprise value is 20.15 billion.
| Market Cap | 14.82B |
| Enterprise Value | 20.15B |
Important Dates
The last earnings date was Wednesday, October 21, 2026.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
BMV:LAB.B has 973.39 million shares outstanding. The number of shares has increased by 33.58% in one year.
| Current Share Class | 973.30M |
| Shares Outstanding | 973.39M |
| Shares Change (YoY) | +33.58% |
| Shares Change (QoQ) | +49.29% |
| Owned by Insiders (%) | 31.07% |
| Owned by Institutions (%) | 23.58% |
| Float | 670.91M |
Valuation Ratios
The trailing PE ratio is 11.91 and the forward PE ratio is 7.78. BMV:LAB.B's PEG ratio is 1.16.
| PE Ratio | 11.91 |
| Forward PE | 7.78 |
| PS Ratio | 0.86 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | 10.38 |
| P/OCF Ratio | 7.73 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.30, with an EV/FCF ratio of 14.12.
| EV / Earnings | 11.73 |
| EV / Sales | 1.17 |
| EV / EBITDA | 5.30 |
| EV / EBIT | 5.86 |
| EV / FCF | 14.12 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.75 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 2.13 |
| Debt / FCF | 5.68 |
| Interest Coverage | 5.07 |
Financial Efficiency
Return on equity (ROE) is 14.72% and return on invested capital (ROIC) is 13.76%.
| Return on Equity (ROE) | 14.72% |
| Return on Assets (ROA) | 8.74% |
| Return on Invested Capital (ROIC) | 13.76% |
| Return on Capital Employed (ROCE) | 19.90% |
| Weighted Average Cost of Capital (WACC) | 5.27% |
| Revenue Per Employee | 9.50M |
| Profits Per Employee | 949,650 |
| Employee Count | 1,801 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.87 |
Taxes
In the past 12 months, BMV:LAB.B has paid 736.02 million in taxes.
| Income Tax | 736.02M |
| Effective Tax Rate | 30.09% |
Stock Price Statistics
The stock price has decreased by -16.17% in the last 52 weeks. The beta is 0.13, so BMV:LAB.B's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -16.17% |
| 50-Day Moving Average | 13.40 |
| 200-Day Moving Average | 15.52 |
| Relative Strength Index (RSI) | 65.48 |
| Average Volume (20 Days) | 4,440,840 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMV:LAB.B had revenue of MXN 17.10 billion and earned 1.71 billion in profits. Earnings per share was 1.28.
| Revenue | 17.10B |
| Gross Profit | 10.71B |
| Operating Income | 3.42B |
| Pretax Income | 2.45B |
| Net Income | 1.71B |
| EBITDA | 3.79B |
| EBIT | 3.42B |
| Earnings Per Share (EPS) | 1.28 |
Balance Sheet
The company has 2.74 billion in cash and 8.06 billion in debt, with a net cash position of -5.32 billion or -5.47 per share.
| Cash & Cash Equivalents | 2.74B |
| Total Debt | 8.06B |
| Net Cash | -5.32B |
| Net Cash Per Share | -5.47 |
| Equity (Book Value) | 12.24B |
| Book Value Per Share | 12.57 |
| Working Capital | 6.10B |
Cash Flow
In the last 12 months, operating cash flow was 1.91 billion and capital expenditures -484.90 million, giving a free cash flow of 1.42 billion.
| Operating Cash Flow | 1.91B |
| Capital Expenditures | -484.90M |
| Depreciation & Amortization | 365.71M |
| Net Borrowing | 572.37M |
| Free Cash Flow | 1.42B |
| FCF Per Share | 1.46 |
Margins
Gross margin is 62.61%, with operating and profit margins of 20.00% and 10.00%.
| Gross Margin | 62.61% |
| Operating Margin | 20.00% |
| Pretax Margin | 14.30% |
| Profit Margin | 10.00% |
| EBITDA Margin | 22.14% |
| EBIT Margin | 20.00% |
| FCF Margin | 8.31% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 5.25%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 5.25% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 45.63% |
| FCF Payout Ratio | 54.82% |
| Buyback Yield | -33.58% |
| Shareholder Yield | -28.30% |
| Earnings Yield | 8.40% |
| FCF Yield | 9.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BMV:LAB.B is 21.33, which is 40.05% higher than the current price. The consensus rating is "Buy".
| Price Target | 21.33 |
| Price Target Difference | 40.05% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 4.37% |
| EPS Growth Forecast (3Y) | 11.07% |
Stock Splits
The last stock split was on August 3, 2010. It was a forward split with a ratio of 2.
| Last Split Date | Aug 3, 2010 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
BMV:LAB.B has an Altman Z-Score of 2.87 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.87 |
| Piotroski F-Score | 5 |